Iron Oxide Nanoparticles-Driven Mitochondrial Renewal Rejuvenates The Aged Bone Marrow Niche
As we age, our bone marrow, the spongy tissue inside our bones, can become less effective. This often involves chronic inflammation and problems with mitochondria, the tiny powerhouses within our cells responsible for energy production. While transferring healthy mitochondria from immune cells, called macrophages, to bone marrow stem cells shows promise for treatment, its effectiveness is limited in older bone marrow because the donor mitochondria might not be fully functional and struggle to integrate with the recipient cells.
Scientists have developed innovative iron oxide nanoparticles, called KGM-PEG-SPIONs, to overcome these challenges. These specially designed nanoparticles work in several ways: they improve the quality of the donor mitochondria by activating a cellular “cleanup” process called autophagy and by helping to build essential iron-sulfur clusters within the mitochondria. They also encourage macrophages to adopt a beneficial M2-like state and enhance the compatibility of the transferred mitochondria with the often-stressful environment of aged bone marrow stem cells.
Once transferred, these revitalized mitochondria restore crucial cellular functions, including energy production (ATP), maintaining electrical balance across cell membranes, and enabling stem cells to differentiate into bone-forming cells. In studies using models of aged osteoporosis, these nanoparticles, delivered through supportive structures, successfully remodeled the immune environment within the bone marrow and significantly promoted the formation of new bone. This approach represents a significant advancement over previous strategies that focused solely on the quantity of mitochondrial transfer or simply altering immune cell types, offering a sophisticated new platform for regeneration based on improving cellular organelles.
Source: link to paper